RVL Pharmaceuticals plc【RVLP】 業績推移・財務諸表

(単位:千ドル) 3Q18 4Q18 1Q19 2Q19 3Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23
売上高 66,344 - 57,126 57,532 65,461 48,649 37,532 57,171 23,880 11,510 2,196 21,444 8,448 10,022 8,832 8,258
売上成長率(%) - - - -
売上原価 32,011 - 29,203 32,643 27,312 20,590 19,995 16,717 13,490 709 1,147 2,144 2,227 2,525 2,299 1,946
売上総利益 34,333 - 27,923 24,888 38,148 28,059 17,537 40,454 10,390 10,801 1,049 19,300 6,221 7,497 6,533 6,312
売上総利益率(%) -
研究開発費 13,309 - 9,764 5,360 8,285 5,688 5,771 3,726 3,310 2,052 1,376 862 1,176 1,044 626 547
販売管理費 17,450 - 21,655 25,512 24,751 21,176 16,555 23,543 18,922 21,047 24,841 23,834 20,169 20,375 16,198 13,886
営業費用 36,933 - 31,419 156,638 161,149 26,864 25,944 46,808 22,232 30,979 26,217 24,696 21,345 21,419 16,824 28,333
営業利益 -2,601 - -3,497 -131,750 -123,001 1,195 -8,407 -6,354 -6,206 -20,178 -25,168 -5,396 -15,124 -13,922 -10,291 -22,021
営業利益率 (%) -
経常(税引前)利益 -7,478 - -7,441 -136,317 -127,328 -2,123 -12,806 -9,765 -9,079 -21,874 -26,023 -6,896 -11,829 -14,383 -11,554 -24,002
経常(税引前)利益率(%) -11.27 - -13.02 -236.94 -194.51 -4.36 -34.12 -17.08 -38.02 -190.04 -1185.02 -32.16 -140.02 -143.51 -130.82 -290.65
法人税等合計 -2,490 - -1,241 -11,663 -14,623 960 193 -1,132 533 94 324 - - - - -
実効税率(%) - - - - - -
純利益 -4,989 -102,360 -6,201 -124,654 -112,705 -3,083 -12,999 -8,633 -9,612 -17,700 -17,859 -6,821 -12,106 -14,446 -11,612 -23,889
純利益率(%) -
一株あたり利益 - - - - - - - - - -0.28 -0.28 -0.08 -0.14 -0.16 -0.12 -0.24
希薄化後一株あたり利益 - - - - - - - - - -0.28 -0.28 -0.08 -0.14 -0.16 -0.12 -0.24
EBITDA - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - -